Daily Health Headlines

Removing Part of Skull After Severe Head Injury Brings Mixed Results

👤by Dennis Thompson 0 comments 🕔Friday, September 9th, 2016

THURSDAY, Sept. 8, 2016 (HealthDay News) -- Removing part of the skull to relieve pressure in the brain following a severe head injury can save a person's life, but the patient is often left permanently disabled, a new clinical trial has determined.

Doctors frequently turn to craniectomy for patients who are suffering from brain swelling as a result of traumatic head injury, but little is known about whether the procedure spares these patients from long-term brain damage.

The new trial found it can drastically reduce risk of death, with about 30 percent of patients dying following the procedure compared to 52 percent of those treated with standard medical care.

However, people treated with a craniectomy were three times more likely to wind up in a vegetative state (6 percent vs. 2 percent), and often were as likely to suffer long-term disabilities as patients receiving standard medical care, the study found.

"We need to be really conscious of the quality of life of patients following this operation, which ranged from vegetative state through varying states of disability to good recovery," said study author Peter Hutchinson. He's a research professor of neuroscience at the University of Cambridge in England.

"Doctors and families will need to be aware of the wide range of possible long-term outcomes when faced with the difficult decision as to whether to subject someone to what is a major operation," Hutchinson said.

The trial involved 408 patients aged 10 to 65 who suffered a traumatic brain injury between 2004 and 2014. Patients who did not respond to standard medical care were randomly assigned to undergo a craniectomy, in which a section of the skull is removed to uncover the brain beneath.

Craniectomy patients had a better survival rate than patients who were treated with medication and less-invasive procedures, the researchers found. However, their injuries still drastically affected their ongoing quality of life:

About 18 percent remained dependent on others for care a year after their surgery, compared with 14 percent of patients who received standard care. About 13 percent were severely disabled but able to be independent at home for extended periods, compared with 4 percent of standard care patients. About 22 percent had moderate disabilities that allowed them to be independent at home but dependent on others in the outside world, compared with 20 percent of standard care patients. About 10 percent experienced a good recovery that led to a resumption of their normal life, compared with 8 percent of standard care patients.

"The study really reiterates what we've already known about decompressive craniectomy," said Dr. Richard Temes, director of the Center for Neurocritical Care at North Shore University Hospital in Manhasset, N.Y. "It is a potentially lifesaving procedure, but if the purpose is to regain or improve function, it doesn't really make that significant an impact."

Brain injury from head trauma comes in two stages, Temes explained.

"There is the initial brain injury which occurs over a period of seconds, and then there's a secondary brain injury which is most commonly due to brain swelling," Temes said. "The decompressive craniectomy is not meant to impact the brain injury that occurred immediately after the injury. It is to prevent secondary brain injury from brain swelling. It's not meant to reverse the brain damage that's already occurred."

One-year follow-up showed that patients who undergo craniectomy do have some chance of recovery, Hutchinson noted. About 45 percent were at least independent at home 12 months later, compared with 32 percent of the standard care group.

But the high risk of permanent disability needs to be weighed prior to surgery, he said.

The study was published online Sept. 8 in the New England Journal of Medicine.

Article Credits / Source

Dennis Thompson / HealthDay

Dennis Thompson wrote this story for HealthDay. HealthDay provides up to the minute breaking health news. Click here to view this full article from HealthDay.

SOURCES: Peter Hutchinson, MBBS, Ph.D., FRCS, research professor, neuroscience, University of Cambridge, England; Richard Temes, M.D., director, Center for Neurocritical Care, North Shore University Hospital, Manhasset, N.Y.; Sept. 8, 2016, New England Journal of Medicine, online

View More Articles From Dennis Thompson 🌎View Article Website

Sponsored Product

Lunar Sleep for $1.95

Lunar Sleep for $1.95

People who have trouble sleeping typically have low levels of melatonin, so melatonin supplements seem like a logical fix for insomnia. There is a high demand for sleep aids, especially in the U.S. The National Health Interview Survey done in 2002, and again in 2007, found 1.6 million US adults were using complementary and alternative sleep aids for insomnia. Lunar Sleep was a top choice. Use Promo Code: Sleep2014 and only pay $1.95 S&H.

Get Lunar Sleep for $1.95

More Neurology Articles

Moms' Rheumatoid Arthritis May Be Linked to Epilepsy Risk in Kids

Moms' Rheumatoid Arthritis May Be Linked to Epilepsy Risk in Kids0

WEDNESDAY, Nov. 16, 2016 (HealthDay News) -- Some children born to mothers with rheumatoid arthritis may have higher-than-average odds of developing epilepsy, a new study suggests. Children born to mothers with rheumatoid arthritis were ...

Brain Implant Lets 'Locked-In' ALS Patient Communicate

Brain Implant Lets 'Locked-In' ALS Patient Communicate0

MONDAY, Nov. 14, 2016 (HealthDay News) -- A high-tech implant has enabled a paralyzed woman with late-stage ALS (amyotrophic lateral sclerosis) to communicate through brain signaling, researchers say. The degenerative disease robbed Hanneke De ...

Blood Test May Someday Diagnose Concussion

Blood Test May Someday Diagnose Concussion0

FRIDAY, Nov. 11, 2016 (HealthDay News) -- A simple blood test may one day diagnose concussions with more than 90 percent certainty, a small Canadian study suggests. This new test is unique, the authors said, because it looks for more than 100 ...

gabapentin (Neurontin, Gralise, Horizant, Fanatrex FusePag)

gabapentin (Neurontin, Gralise, Horizant, Fanatrex FusePag)0

home / neurology center / neurology a-z list / gabapentin index / gabapentin (neurontin, gralise, horizant, fanatrex fusepag) drug monograph Pharmacy Author: Omudhome Ogbru, PharmD Omudhome Ogbru, ...

MS Symptoms May Develop Earlier in Darker, Cooler Climes

MS Symptoms May Develop Earlier in Darker, Cooler Climes0

THURSDAY, Nov. 3, 2016 (HealthDay News) -- The farther from the Equator someone with multiple sclerosis lives, the earlier symptoms begin, a new study finds. MS is a progressive disease affecting the central nervous system. Although symptoms ...

View More Neurology Articles


Write a Comment

Your email address will not be published. Required fields are marked *

Our Mailing List

Subscribe to our mailing list to get the latest health news as it breaks!

Your information will not be shared with anyone!